FIBROSARCOMA

FIBROSARCOMA was reported 79 times

These drug classes are most commonly taken by patients reporting FIBROSARCOMA:

# Drug Count
0 Corticosteroid [EPC] 15
1 Tumor Necrosis Factor Blocker [EPC] 10
2 Alkylating Drug [EPC] 7
3 Kinase Inhibitor [EPC] 7
4 mTOR Inhibitor Immunosuppressant [EPC] 4
5 Actinomycin [EPC] 3
6 Folate Analog Metabolic Inhibitor [EPC] 3
7 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3
8 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3
9 Nonsteroidal Anti-inflammatory Drug [EPC] 3
10 RANK Ligand Inhibitor [EPC] 3
11 Vitamin C [EPC] 3
12 Angiotensin 2 Receptor Blocker [EPC] 2
13 Cytochrome P450 3A Inhibitor [EPC] 2
14 HMG-CoA Reductase Inhibitor [EPC] 2
15 Lymphocyte Growth Factor [EPC] 2
16 Nucleoside Metabolic Inhibitor [EPC] 2
17 Opioid Agonist [EPC] 2
18 Protease Inhibitor [EPC] 2
19 Vitamin B12 [EPC] 2
20 Vitamin D [EPC] 2
21 gamma-Aminobutyric Acid-ergic Agonist [EPC] 2
22 Angiotensin Converting Enzyme Inhibitor [EPC] 1
23 Antimetabolite [EPC] 1
24 Benzodiazepine [EPC] 1
25 CD52-directed Cytolytic Antibody [EPC] 1
26 Calcium Channel Blocker [EPC] 1
27 Dihydropyridine Calcium Channel Blocker [EPC] 1
28 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1
29 Ergot Derivative [EPC] 1
30 Erythropoiesis-stimulating Agent [EPC] 1
31 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
32 Interferon beta [EPC] 1
33 Interleukin-6 Receptor Antagonist [EPC] 1
34 Janus Kinase Inhibitor [EPC] 1
35 Non-narcotic Antitussive [EPC] 1
36 Parathyroid Hormone Analog [EPC] 1
37 Parenteral Iron Replacement [EPC] 1
38 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
39 Platelet Aggregation Inhibitor [EPC] 1
40 Platinum-based Drug [EPC] 1
41 Purine Antimetabolite [EPC] 1
42 Retinoid [EPC] 1
43 Selective T Cell Costimulation Modulator [EPC] 1
44 Thalidomide Analog [EPC] 1
45 Thiazide Diuretic [EPC] 1
46 Topoisomerase Inhibitor [EPC] 1
47 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
48 Xanthine Oxidase Inhibitor [EPC] 1
49 beta-Adrenergic Blocker [EPC] 1